IIH
MCID: INT303
MIFTS: 50

Intracranial Hypertension, Idiopathic (IIH)

Categories: Cardiovascular diseases, Eye diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Intracranial Hypertension, Idiopathic

MalaCards integrated aliases for Intracranial Hypertension, Idiopathic:

Name: Intracranial Hypertension, Idiopathic 57 53
Pseudotumor Cerebri 57 12 76 53 54 59 55 44 15 73
Idiopathic Intracranial Hypertension 12 53 59
Benign Intracranial Hypertension 12 54 59
Iih 53 59
Benign Intracran. Hypt. 12

Characteristics:

OMIM:

57
Inheritance:
autosomal recessive


HPO:

32
intracranial hypertension, idiopathic:
Inheritance autosomal recessive inheritance


Classifications:

Orphanet: 59  
Rare neurological diseases


External Ids:

OMIM 57 243200
Disease Ontology 12 DOID:11459
ICD10 33 G93.2
ICD9CM 35 348.2
MeSH 44 D011559
NCIt 50 C85035
SNOMED-CT 68 68267002
Orphanet 59 ORPHA238624
UMLS via Orphanet 74 C0033845
ICD10 via Orphanet 34 G93.2
MedGen 42 C0033845
UMLS 73 C0033845

Summaries for Intracranial Hypertension, Idiopathic

NIH Rare Diseases : 53 Idiopathic intracranial hypertension (IIH), formerly known as pseudotumor cerebri, is a condition that affects the brain. Pseudotumor cerebri literally translates to "false brain tumor." This term was used because symptoms of IIH resemble those of brain tumors depsite no tumor being present. Symptoms of IIH may include severe headache, nausea and vomiting, altered vision, and pulsating sounds within the head. A person with IIH may also have symptoms such as a stiff neck, back or arm pain, eye pain, and memory problems. If the condition remains untreated, permanent visual loss or blindness may develop. While the exact underlying cause of IIH is not known (idiopathic), it is likely due to high fluid pressure within the skull that is due to buildup, or poor absorption, of cerebrospinal fluid (CSF). IIH most often (but not always) occurs in young, overweight, females. When symptoms of intracranial pressure have an identifiable cause such as another underlying disease or medication, the condition is instead referred to as secondary IH. Treatment for IIH may include medications called carbonic anhydrase inhibitors to control the production of CSF. In some cases, weight loss may also be recommended. However, medications and/or weight loss are not effective in all cases. In severe cases that do not respond to medication and weight loss, surgery may be needed to relieve symptoms and/or preserve vision.

MalaCards based summary : Intracranial Hypertension, Idiopathic, also known as pseudotumor cerebri, is related to intracranial hypertension and communicating hydrocephalus, and has symptoms including neurologic symptoms An important gene associated with Intracranial Hypertension, Idiopathic is SSTR1 (Somatostatin Receptor 1), and among its related pathways/superpathways is Endochondral Ossification. The drugs Minocycline and Doxycycline have been mentioned in the context of this disorder. Affiliated tissues include brain, eye and bone, and related phenotypes are hypertension and increased intracranial pressure

NINDS : 54 Pseudotumor cerebri literally means "false brain tumor." It is likely due to high pressure within the skull caused by the buildup or poor absorption of cerebrospinal fluid (CSF). The disorder is most common in women between the ages of 20 and 50. Symptoms of pseudotumor cerebri, which include headache, nausea, vomiting, and pulsating sounds within the head, closely mimic symptoms of large brain tumors.

Wikipedia : 76 Idiopathic intracranial hypertension (IIH) is a condition characterized by increased intracranial... more...

Description from OMIM: 243200

Related Diseases for Intracranial Hypertension, Idiopathic

Diseases related to Intracranial Hypertension, Idiopathic via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 229)
# Related Disease Score Top Affiliating Genes
1 intracranial hypertension 31.0 AQP4 SSTR1
2 communicating hydrocephalus 30.0 AQP4 OGG1
3 optic nerve disease 29.8 AQP4 OPN4
4 papilledema 29.4 OGG1 PCLO SEMA6B
5 congenital disorder of glycosylation, type iih 12.5
6 empty sella syndrome 11.7
7 galactokinase deficiency 11.6
8 idiopathic infantile hypercalcemia 11.4
9 thrombosis 10.5
10 systemic lupus erythematosus 10.4
11 acute promyelocytic leukemia 10.4
12 leukemia 10.4
13 lupus erythematosus 10.4
14 headache 10.4
15 hypothyroidism 10.3
16 lyme disease 10.3
17 hydrocephalus 10.3
18 xeroderma pigmentosum, variant type 10.2
19 rickets 10.2
20 sleep apnea 10.2
21 hypervitaminosis a 10.2
22 adenoma 10.2
23 aplastic anemia 10.1
24 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 10.1
25 hypophosphatasia 10.1
26 pituitary adenoma 10.1
27 viral infectious disease 10.1
28 meningitis 10.1
29 chiari malformation 10.1
30 spontaneous intracranial hypotension 10.1
31 arteriovenous fistula 10.0
32 iron metabolism disease 10.0
33 neurofibromatosis, type ii 10.0
34 pseudopapilledema 10.0
35 thrombophilia due to thrombin defect 10.0
36 torticollis 10.0
37 panencephalitis, subacute sclerosing 10.0
38 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 10.0
39 hyperprolactinemia 10.0
40 arthritis 10.0
41 bipolar disorder 10.0
42 brain injury 10.0
43 hepatitis 10.0
44 morbid obesity 10.0
45 traumatic brain injury 10.0
46 inflammatory bowel disease 10.0
47 lymphoma 10.0
48 rhabdomyosarcoma 10.0
49 uremia 10.0
50 hyperthyroidism 10.0

Comorbidity relations with Intracranial Hypertension, Idiopathic via Phenotypic Disease Network (PDN):


Acute Cystitis Hypertension, Essential

Graphical network of the top 20 diseases related to Intracranial Hypertension, Idiopathic:



Diseases related to Intracranial Hypertension, Idiopathic

Symptoms & Phenotypes for Intracranial Hypertension, Idiopathic

Symptoms via clinical synopsis from OMIM:

57
H E E N T:
papilledema
pseudotumor cerebri
idiopathic intracranial hypertension


Clinical features from OMIM:

243200

Human phenotypes related to Intracranial Hypertension, Idiopathic:

32
# Description HPO Frequency HPO Source Accession
1 hypertension 32 HP:0000822
2 increased intracranial pressure 32 HP:0002516
3 papilledema 32 HP:0001085

UMLS symptoms related to Intracranial Hypertension, Idiopathic:


neurologic symptoms

GenomeRNAi Phenotypes related to Intracranial Hypertension, Idiopathic according to GeneCards Suite gene sharing:

26 (show all 15)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-110 9.55 IRF6
2 Increased shRNA abundance (Z-score > 2) GR00366-A-115 9.55 IRF6 OGG1 OPN4
3 Increased shRNA abundance (Z-score > 2) GR00366-A-12 9.55 OGG1
4 Increased shRNA abundance (Z-score > 2) GR00366-A-123 9.55 OGG1
5 Increased shRNA abundance (Z-score > 2) GR00366-A-130 9.55 OPN4
6 Increased shRNA abundance (Z-score > 2) GR00366-A-169 9.55 IRF6
7 Increased shRNA abundance (Z-score > 2) GR00366-A-176 9.55 IRF6
8 Increased shRNA abundance (Z-score > 2) GR00366-A-19 9.55 OGG1
9 Increased shRNA abundance (Z-score > 2) GR00366-A-196 9.55 OGG1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-202 9.55 OGG1
11 Increased shRNA abundance (Z-score > 2) GR00366-A-208 9.55 OGG1
12 Increased shRNA abundance (Z-score > 2) GR00366-A-4 9.55 OPN4
13 Increased shRNA abundance (Z-score > 2) GR00366-A-43 9.55 IRF6
14 Increased shRNA abundance (Z-score > 2) GR00366-A-52 9.55 IRF6
15 Increased shRNA abundance (Z-score > 2) GR00366-A-81 9.55 OPN4

MGI Mouse Phenotypes related to Intracranial Hypertension, Idiopathic:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.7 GHR IHH IRF6 OGG1 OPN4 RBP4
2 nervous system MP:0003631 9.56 AQP4 GHR IHH OGG1 OPN4 PCLO
3 vision/eye MP:0005391 9.02 AQP4 IHH OPN4 RBP4 SSTR1

Drugs & Therapeutics for Intracranial Hypertension, Idiopathic

Drugs for Intracranial Hypertension, Idiopathic (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 67)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Minocycline Approved, Investigational Phase 4,Phase 2 10118-90-8 5281021
2
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2 564-25-0 54671203
3
Lymecycline Approved, Investigational Phase 4 992-21-2 5280963
4
Isotretinoin Approved Phase 4 4759-48-2 5538 5282379
5 Hormones Phase 4
6 Hormone Antagonists Phase 4
7 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4
8 Anti-Bacterial Agents Phase 4,Phase 2,Not Applicable
9 Anti-Infective Agents Phase 4,Phase 2
10 Dermatologic Agents Phase 4
11
Naproxen Approved, Vet_approved Phase 2, Phase 3 22204-53-1 1302 156391
12
Aspirin Approved, Vet_approved Phase 2, Phase 3,Not Applicable 50-78-2 2244
13
Codeine Approved, Illicit Phase 2, Phase 3 76-57-3 5284371
14
Guaifenesin Approved, Investigational, Vet_approved Phase 2, Phase 3 93-14-1 3516
15
Acetaminophen Approved Phase 2, Phase 3 103-90-2 1983
16
Acetazolamide Approved, Vet_approved Phase 2, Phase 3,Phase 3 59-66-5 1986
17
Ibuprofen Approved Phase 2, Phase 3 15687-27-1 3672
18 diuretics Phase 2, Phase 3,Phase 3
19 Analgesics, Non-Narcotic Phase 2, Phase 3
20 Narcotics Phase 2, Phase 3
21 Anticonvulsants Phase 2, Phase 3,Phase 3
22 Central Nervous System Depressants Phase 2, Phase 3
23 Carbonic Anhydrase Inhibitors Phase 2, Phase 3,Phase 3
24 Chlorpheniramine, phenylpropanolamine drug combination Phase 2, Phase 3
25 Anti-Inflammatory Agents, Non-Steroidal Phase 2, Phase 3
26 Anti-Inflammatory Agents Phase 2, Phase 3
27 Analgesics Phase 2, Phase 3
28 Cyclooxygenase Inhibitors Phase 2, Phase 3
29 Respiratory System Agents Phase 2, Phase 3
30 Peripheral Nervous System Agents Phase 2, Phase 3
31 Analgesics, Opioid Phase 2, Phase 3
32 Antipyretics Phase 2, Phase 3
33 Fibrinolytic Agents Phase 2, Phase 3
34 Platelet Aggregation Inhibitors Phase 2, Phase 3
35 Antirheumatic Agents Phase 2, Phase 3
36 Antitussive Agents Phase 2, Phase 3
37 Natriuretic Agents Phase 2, Phase 3,Phase 3
38
Nicotinamide Approved, Investigational Phase 2 98-92-0 936
39
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
40
Niacin Approved, Investigational, Nutraceutical Phase 2 59-67-6 938
41 Vitamin B9 Phase 2
42 Vitamins Phase 2,Not Applicable
43 Vitamin B3 Phase 2
44 Trace Elements Phase 2,Not Applicable
45 Micronutrients Phase 2,Not Applicable
46 Nicotinic Acids Phase 2
47 Folate Phase 2
48 Vitamin B Complex Phase 2
49 Antimalarials Phase 2
50 Antiparasitic Agents Phase 2

Interventional clinical trials:

(show all 33)
# Name Status NCT ID Phase Drugs
1 Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome Completed NCT00266656 Phase 4 Humatrope
2 Antiacne Medications Pseudotumor Cerebri Recruiting NCT02149615 Phase 4
3 ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) Patients Withdrawn NCT00793416 Phase 4
4 Idiopathic Intracranial Hypertension Treatment Trial Completed NCT01003639 Phase 2, Phase 3 Acetazolamide;Placebo
5 Surgical Idiopathic Intracranial Hypertension Treatment Trial Recruiting NCT03501966 Phase 3 Acetazolamide
6 Normal Pressure Hydrocephalus Treatment by Acetazolamide Terminated NCT02163330 Phase 3 Acetazolamide;sugar pill
7 Study the Safety and Efficacy of Bone Marrow Derived Autologous Cells for the Treatment of Optic Nerve Disease Unknown status NCT01834079 Phase 1, Phase 2
8 Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. Completed NCT02017444 Phase 2 AZD4017
9 BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris Completed NCT02815332 Phase 2 BPX-01 1% Minocycline Topical Gel;BPX-01 2% Minocycline Topical Gel;BPX-01 Vehicle Topical Gel
10 Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris Completed NCT01320033 Phase 2 CD2475/101 40 mg Tablets;Doxycycline 100 mg Capsules;Placebo Tablet, and Placebo Capsule
11 Acetazolamide for Treating NPH in Shunt-candidates Patients Recruiting NCT03779594 Phase 2 Acetazolamide
12 Venous Sinus Stenting for Idiopathic Intracranial Hypertension Refractory to Medical Therapy Recruiting NCT01407809 Phase 1
13 Magnetic Resonance Venography Pre- and Post-Treatment in Patients With Idiopathic Intracranial Hypertension Unknown status NCT02394067
14 OCT Imaging of Papilledema in Pediatric Idiopathic Intracranial Hypertension Unknown status NCT02665858 Not Applicable
15 Neurocognitive Outcome in Children Who Suffered From Idiopathic Increased Intracranial Hypertension (IIH) Unknown status NCT02857335 Not Applicable
16 Oxidative Stress, Low Grade Inflammation, Tissue Breakdown and Biomarkers in Cerebrospinal Fluid of A-T Unknown status NCT02285348 Not Applicable
17 The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study Completed NCT00071903
18 High/Low Dose Vit A in Diarrhea/ALRI in Severe PEM Completed NCT00388921 Not Applicable Vitamin A
19 Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension Recruiting NCT02143258 Not Applicable
20 Venous Sinus Stenting With the River Stent in IIH Recruiting NCT03556085 Not Applicable
21 Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome Recruiting NCT02896452
22 Evaluating Raised Intracranial Pressure Using MR Elastography Recruiting NCT03096743 Not Applicable
23 Intracranial Pressure vs Percentage Body Fat Recruiting NCT03144297
24 Relaxin in Multiple Sclerosis (MS) Recruiting NCT01909492
25 Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE) Recruiting NCT03373045
26 An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH Active, not recruiting NCT02124486 Not Applicable
27 Multifocal Chromatic Pupilloperimetry in Patients With Pseudotumor Cerebri and Healthy Subjects. Not yet recruiting NCT03304314 Not Applicable
28 Operative Procedures vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial Not yet recruiting NCT02513914 Not Applicable
29 Phenotypic and Functional Study of 4BL B Cells in Multiple Sclerosis (MS) Not yet recruiting NCT03796611
30 Axial Length and Central Corneal Thickness in Benign Intracranial Hypertension Terminated NCT02541994 Not Applicable
31 Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement Terminated NCT01863381 Not Applicable
32 Disc Edema in Patients With Chronic Kidney Disease Withdrawn NCT00769834
33 Analysis of Translaminar Pressure Gradient Using Noninvasive Cerebrospinal Fluid Pressure Monitoring Withdrawn NCT02828891 Not Applicable

Search NIH Clinical Center for Intracranial Hypertension, Idiopathic

Cochrane evidence based reviews: pseudotumor cerebri

Genetic Tests for Intracranial Hypertension, Idiopathic

Anatomical Context for Intracranial Hypertension, Idiopathic

MalaCards organs/tissues related to Intracranial Hypertension, Idiopathic:

41
Brain, Eye, Bone, Pituitary, Thyroid, Bone Marrow, Ovary

Publications for Intracranial Hypertension, Idiopathic

Articles related to Intracranial Hypertension, Idiopathic:

(show top 50) (show all 731)
# Title Authors Year
1
Pseudotumor cerebri syndrome in a patient with narcolepsy type 1. ( 29195824 )
2018
2
Pseudotumor cerebri in kaposiform lymphangiomatosis: a case report and pathogenetic hypothesis. ( 29654359 )
2018
3
Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri. ( 29961386 )
2018
4
Non-Syndromic Craniosynostosis Mimicking Primary Pseudotumor Cerebri Syndrome. ( 30474204 )
2018
5
Headache Characteristics in Children With Pseudotumor Cerebri Syndrome, Elevated Opening Pressure Without Papilledema, and Normal Opening Pressure: A Retrospective Cohort Study. ( 30137653 )
2018
6
Epidural Blood Patch for Postdural Puncture Headache due to Lumboperitoneal Shunt Placement in a Patient With Pseudotumor Cerebri: A Case Report. ( 30272589 )
2018
7
Evidence of Diplopia in Children's Headache Drawings Helps to Differentiate Pseudotumor Cerebri From Migraine. ( 29413638 )
2018
8
Secondary intracranial hypertension (pseudotumor cerebri) presenting as post-traumatic headache in mild traumatic brain injury: a case series. ( 29230542 )
2018
9
Pseudotumor cerebri and lung cancer-associated jugular vein thrombosis: Role of anatomical variations of torcular herophili. ( 30450429 )
2018
10
Pseudotumor cerebri as the presentation of Lyme disease in a non-endemic area. ( 29602888 )
2018
11
Atypical Anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. ( 30300850 )
2018
12
Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation. ( 29938337 )
2018
13
Prognostic value of JAK2V617F mutation in pseudotumor cerebri associated with cerebral venous sinus thrombosis. ( 30251405 )
2018
14
Bariatric surgery as a treatment for pseudotumor cerebri: case study and narrative review of the literature. ( 28562736 )
2018
15
Ocular ultrasound for monitoring pseudotumor cerebri syndrome. ( 29243006 )
2018
16
Magnetic resonance elastography to estimate brain stiffness: Measurement reproducibility and its estimate in pseudotumor cerebri patients. ( 29459315 )
2018
17
Laparoscopy in the management of lumboperitoneal shunt catheter in obese patients with pseudotumor cerebri. ( 29519994 )
2018
18
Reduced Suprathreshold Odor Identification in Patients with Pseudotumor Cerebri: A Non-Randomized Prospective Study. ( 29658205 )
2018
19
An Up to Date Review of Pseudotumor Cerebri Syndrome. ( 29721718 )
2018
20
Clinical and Prognostic Significance of Cerebrospinal Fluid Opening and Closing Pressures in Pediatric Pseudotumor Cerebri Syndrome. ( 29753572 )
2018
21
Bariatric surgery and its impact on pseudotumor cerebri: A case report. ( 29780918 )
2018
22
Pseudotumor Cerebri Syndrome with Resolution After Discontinuing High Vitamin A Containing Dietary Supplement: Case Report and Review. ( 29796052 )
2018
23
Pseudotumor cerebri syndrome in a pregnant woman with systemic lupus erythematous. ( 29809325 )
2018
24
Pseudotumor cerebri syndrome (PCTS) - Losing sight in patients and doctors with regards to a growing epidemic. ( 29954644 )
2018
25
Valsalva-triggered pseudotumor cerebri syndrome: Case series and pathogenetic implications. ( 30021914 )
2018
26
Pseudotumor Cerebri Following Nexplanon® Implantation. ( 30034970 )
2018
27
Nuances of Endovascular Treatment of Transverse/Sigmoid Sinus Stenosis With Stenting Venoplasty in a Patient With Pseudotumor Cerebri: 2-Dimensional Operative Video. ( 30060093 )
2018
28
Methotrexate-induced pseudotumor cerebri in a patient with juvenile idiopathic arthritis. ( 30083940 )
2018
29
Pseudotumor cerebri comorbid with meningioma: A review and case series. ( 30105128 )
2018
30
Pseudotumor Cerebri Syndrome is the Best Term for This Condition. ( 30501891 )
2018
31
Medication-Related Pseudotumor Cerebri Syndrome. ( 27786584 )
2017
32
[Pseudotumor cerebri due to taking minocycline]. ( 28653520 )
2017
33
Normal Pressure Pseudotumor Cerebri: A Series of Six Patients. ( 27593779 )
2017
34
Probable pseudotumor cerebri complex in 25 children. Further support of a concept. ( 27825557 )
2017
35
Therapeutic approaches to pediatric pseudotumor cerebri: New insights from literature data. ( 27903844 )
2017
36
How high is a 'high' CSF opening pressure in paediatric pseudotumor cerebri? ( 28187821 )
2017
37
Pseudotumor cerebri syndrome in childhood: incidence, clinical profile and risk factors in a national prospective population-based cohort study. ( 28356250 )
2017
38
Is Pseudotumor Cerebri An Unusual Expression of Chiari Syndrome? A Case Report and Review of the Literature. ( 28537352 )
2017
39
Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study. ( 28754842 )
2017
40
Chiari I malformation with underlying pseudotumor cerebri: Poor symptom relief following posterior decompression surgery. ( 28756364 )
2017
41
Treatment Response in Pediatric Patients With Pseudotumor Cerebri Syndrome. ( 28787297 )
2017
42
Pediatric Pseudotumor Cerebri Syndrome. ( 28806347 )
2017
43
Pediatric Pseudotumor Cerebri Syndrome: Diagnosis, Classification, and Underlying Pathophysiology. ( 28941525 )
2017
44
Neurobrucellosis Presenting as Pseudotumor Cerebri: First Report from Oman. ( 29218128 )
2017
45
Pseudotumor cerebri syndrome without cerebral venous sinus thrombosis in Behçet's disease. ( 29246633 )
2017
46
An Estimation of the Risk of Pseudotumor Cerebri among Users of the Levonorgestrel Intrauterine Device. ( 29344058 )
2017
47
Optociliary Shunt Vessels: Role in Diagnosis and Treatment of Atypical Pseudotumor Cerebri. ( 29344065 )
2017
48
Pseudotumor Cerebri and Glymphatic Dysfunction. ( 29387036 )
2017
49
Pseudotumor Cerebri in Acute Promyelocytic Leukemia Patients on Intergroup Protocol 0129: Clinical Description and Recommendations forA New Diagnostic Criteria. ( 26724834 )
2016
50
Idiopathic Intracranial Hypertension (Pseudotumor Cerebri). ( 27602531 )
2016

Variations for Intracranial Hypertension, Idiopathic

Expression for Intracranial Hypertension, Idiopathic

Search GEO for disease gene expression data for Intracranial Hypertension, Idiopathic.

Pathways for Intracranial Hypertension, Idiopathic

Pathways related to Intracranial Hypertension, Idiopathic according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.44 GHR IHH

GO Terms for Intracranial Hypertension, Idiopathic

Sources for Intracranial Hypertension, Idiopathic

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....